Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$171,844
+$50,674 QoQ
Shares Held
63,646
-37.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Derivatives in FATE
reported options exposure · as of Sep 30, 2020CallValue
$74,000
CallShares
17,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. FATE ranks #261 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in FATE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,844 | 63,646 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $121,170 | 100,975 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $168,837 | 172,283 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $168,637 | 133,839 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $136,854 | 122,192 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $81,320 | 102,938 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $152,450 | 92,395 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $206,887 | 59,111 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $187,786 | 57,252 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $301,034 | 41,013 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $143,390 | 38,340 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $72,726 | 34,305 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,009,709 | 212,124 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,532,883 | 268,927 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $511,470 | 50,691 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,044,751 | 46,620 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,130,188 | 45,609 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,520,768 | 142,398 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,657,302 | 182,145 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,587,262 | 381,091 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,360,279 | 326,769 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,150,256 | 208,008 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,707,578 | 227,731 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $9,914,397 | 248,046 | Shares | Defined | 2020-11-05 | |
| 2020-09-30 | $74,000 | 17,000 | Call | Defined | 2020-11-05 | |
| 2020-06-30 | $11,795,776 | 343,800 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $9,409,286 | 423,651 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||